FDA Drug Info Rounds pharmacists discuss medication disposal options.

FDA Drug Info Rounds pharmacists discuss the application of the United States Pharmacopeia’s Monograph Naming Policy for Salt Drug Substances in Drug Products and Compounded Preparations.

FDA Drug Info Rounds pharmacists discuss expanded access to investigational drugs.

FDA Drug Info Rounds pharmacists discuss key points pharmacists should counsel their patients on prior to travel.

FDA Drug Info Rounds pharmacists discuss the management of drug shortages and how the FDA’s role has changed in recent years.

FDA Drug Info Rounds pharmacists discuss how to search the Electronic Orange Book for generic equivalents, patents, and exclusivity.

FDA Drug Info Rounds pharmacists discuss FDA's responsibility for reviewing and approving new product names

FDA Drug Info Rounds pharmacists talk about the benefit risk balance, and how health care professionals may approach this topic with their patients.

FDA Drug Info Rounds pharmacists discuss the vital role that pharmacists play in assisting the FDA with communicating drug safety messages.

FDA Drug Info Rounds pharmacists discuss FDA's role in responding to and mitigating drug shortages.